Cite
HARVARD Citation
Aapro, M. et al. (n.d.). Treatment patterns and outcomes in patients with breast cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy-induced/febrile neutropenia: Results from the MONITOR-GCSF study. European journal of cancer. pp. S53-. [Online].